Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Enact Holdings, Inc.ACT · Entity 3734 | EVP and Chief Risk Officer | September 17, 2026 | September 21, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Enact Holdings, Inc.
Report date September 17, 2026 · Filed September 21, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 2,539 |
Reported balance
After 2026-09-17 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-09-17 · Grant · Acquired 13 · Balance 2,539 F1: Each restricted stock unit will settle into shares of Issuer common stock on a 1:1 basis. F3: Additional restricted stock units acquired pursuant to reinvestment terms in the restricted stock unit award agreement resulting from a quarterly dividend at $0.24 per share, paid on September 17, 2026. F2: Restricted Stock Units vest and convert to Common Stock in three equal annual installments beginning on February 16, 2025 |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 4,117 |
Reported balance
After 2026-09-17 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-09-17 · Grant · Acquired 21 · Balance 4,117 F1: Each restricted stock unit will settle into shares of Issuer common stock on a 1:1 basis. F3: Additional restricted stock units acquired pursuant to reinvestment terms in the restricted stock unit award agreement resulting from a quarterly dividend at $0.24 per share, paid on September 17, 2026. F4: Restricted Stock Units vest and convert to Common Stock in three equal annual installments beginning on February 21, 2026 |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 6,936 |
Reported balance
After 2026-09-17 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-09-17 · Grant · Acquired 35 · Balance 6,936 F1: Each restricted stock unit will settle into shares of Issuer common stock on a 1:1 basis. F3: Additional restricted stock units acquired pursuant to reinvestment terms in the restricted stock unit award agreement resulting from a quarterly dividend at $0.24 per share, paid on September 17, 2026. F5: Restricted Stock Units vest and convert to Common Stock in three equal annual installments beginning on February 13, 2027 |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit will settle into shares of Issuer common stock on a 1:1 basis.
F2: Restricted Stock Units vest and convert to Common Stock in three equal annual installments beginning on February 16, 2025
F3: Additional restricted stock units acquired pursuant to reinvestment terms in the restricted stock unit award agreement resulting from a quarterly dividend at $0.24 per share, paid on September 17, 2026.
F4: Restricted Stock Units vest and convert to Common Stock in three equal annual installments beginning on February 21, 2026
F5: Restricted Stock Units vest and convert to Common Stock in three equal annual installments beginning on February 13, 2027
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 26, 2022 Filed May 31, 2022 20:36 UTC | Enact Holdings, Inc. ACT · Entity 3734 | GrantRestricted Stock Units · Derivative | 44 | $0.00 | $0.00 |
DisclosureSEC source: 0001823529-22-000131 · wf-form4_165402939480947.xml · derivative · entry 1 Derstine Michael · CIK 0001858567 · EVP and Chief Risk Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,575 Underlying: Common Stock · 44 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit will settle into shares of Issuer common stock on a 1:1 basis. F3 · price: Additional restricted stock units acquired pursuant to reinvestment terms under the award agreement from a dividend paid on May 26, 2022, at $0.14 per share. F2 · derivative.exercise_date: Restricted Stock Units vest and convert to Common Stock in three equal annual installments beginning on February 11, 2023 F2 · derivative.expiration_date: Restricted Stock Units vest and convert to Common Stock in three equal annual installments beginning on February 11, 2023 Read SEC document |
| February 11, 2022 Filed Feb 16, 2022 01:09 UTC | Enact Holdings, Inc. ACT · Entity 3734 | GrantRestricted Stock Units · Derivative | 7,531 | $0.00 | $0.00 |
DisclosureSEC source: 0001823529-22-000030 · wf-form4_164497377309064.xml · derivative · entry 1 Derstine Michael · CIK 0001858567 · EVP and Chief Risk Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,803 Underlying: Common Stock · 7,531 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit will settle into shares of Issuer common stock on a 1:1 basis. F2 · derivative.exercise_date: Restricted Stock Units vest and convert to Common Stock in three equal annual installments beginning on February 11, 2023. F2 · derivative.expiration_date: Restricted Stock Units vest and convert to Common Stock in three equal annual installments beginning on February 11, 2023. Read SEC document |
| December 15, 2021 Filed Dec 17, 2021 21:08 UTC | Enact Holdings, Inc. ACT · Entity 3734 | GrantRestricted Stock Units · Derivative | 1,219 | $0.00 | $0.00 |
DisclosureSEC source: 0001823529-21-000044 · wf-form4_163977530467297.xml · derivative · entry 1 Derstine Michael · CIK 0001858567 · EVP and Chief Risk Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,272 Underlying: Common Stock · 1,219 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit will settle into shares of Issuer common stock on a 1:1 basis. F3 · price: Additional restricted stock units acquired pursuant to reinvestment terms under the restricted stock unit award agreement from a dividend paid on December 15, 2021, at $1.23 per share. F2 · derivative.exercise_date: These restricted stock units will vest on the third anniversary of the grant date. F2 · derivative.expiration_date: These restricted stock units will vest on the third anniversary of the grant date. Read SEC document |
| September 20, 2021 Filed Sep 20, 2021 20:06 UTC | Enact Holdings, Inc. ACT · Entity 3734 | PurchaseCommon Stock | 1,000 | $19.00 | $19,000.00 |
DisclosureSEC source: 0001209191-21-056864 · doc4.xml · nonDerivative · entry 1 Derstine Michael · CIK 0001858567 · EVP and Chief Risk Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000 F1 · kind: Represents shares purchased directly from an underwriter under the directed share program in connection with the Issuer's initial public offering of common stock, which closed on September 20, 2021. Read SEC document |
| September 15, 2021 Filed Sep 17, 2021 20:07 UTC | Enact Holdings, Inc. ACT · Entity 3734 | GrantRestricted Stock Units · Derivative | 21,053 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-056614 · doc4.xml · derivative · entry 1 Derstine Michael · CIK 0001858567 · EVP and Chief Risk Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,053 Underlying: Common Stock · 21,053 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit will settle into shares of Issuer common stock on a 1:1 basis. F2 · derivative.exercise_date: These restricted stock units will vest on the third anniversary of the grant date. F2 · derivative.expiration_date: These restricted stock units will vest on the third anniversary of the grant date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.